Better MRI for non-mass breast lesions: a diagnostic study
Part of Cancer clinical trials.
This trial tests whether a special MRI technique (multiparametric DCE-MRI) can more accurately detect breast lesions that look like abnormal areas rather than lumps. If you have one of these 'non-mass' lesions on an MRI or other imaging, this study may help improve diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a female of any age.
- You have a breast lesion that is described as 'non-mass' (an area of abnormal tissue, not a defined lump) on MRI or other imaging.
- You have had both an MRI and a targeted ultrasound of your breast.
- You do not have a heart pacemaker, severe claustrophobia, or metal implants that are not MRI-safe.
- You do not have severe kidney problems, are not pregnant, and have no history of severe allergic reaction to gadolinium contrast dye.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests advanced MRI imaging techniques to better diagnose breast cancer and evaluate treatment response. If you have a suspicious breast lesion, this trial may help doctors see it more clearly before biopsy or surgery.
This study uses a breast MRI scan to look at suspicious areas in the breast. It may help doctors better tell which breast changes need closer follow-up like a biopsy.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This trial tests a new, faster MRI technique (called ultra-high b-value DWI) to see if it can find breast cancer as well as the standard MRI. It is for women who have a suspicious breast finding (BIRADS 4a), are high risk, have suspicious lymph nodes, or have dense breasts and need an MRI.
This study tests a new way to read breast MRI scans that doesn't require injecting contrast dye into your bloodstream. Researchers want to see if this method can accurately identify cancer and assess risk, potentially making breast imaging safer and simpler.
This study compares two advanced breast imaging methods—contrast-enhanced mammography (CEM) and breast MRI—to see which is better at finding cancer, especially in women with dense breasts or unclear mammogram results. If you are being referred for one of these exams, you may be able to join and help doctors learn which test works best.
Hear when a new Non Mass Breast Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.